HBV mutation literature information.


  Acute liver injury following infection with a cytopathic strain of duck hepatitis B virus.
 PMID: 9918936       1999       Hepatology (Baltimore, Md.)
Abstract: A single amino acid change of glycine to glutamic acid at position 133 (G133E) in the preS protein of duck hepatitis B virus (DHBV) caused an increase in the intranuclear pool of viral covalently closed circular DNA (cccDNA), resulting in a transient elevation of viral replication and eventual hepatocyte destruction.
Abstract: Birds infected with the G133E virus had increased periportal cellular proliferation and numerous lysed apoptotic hepatocytes following 100% infection of hepatocytes.
Abstract: In vivo viral infection with the G133E virus was compared with infection with wild-type virus over a 72-day period.
Abstract: The liver damage within G133E virus-infected birds subsided over time, resulting in mi


  Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation.
 PMID: 9425945       1998       Hepatology (Baltimore, Md.)
Abstract: In addition to already-known variants sG145R/K/E, we could demonstrate that newly described variants sX144G and sG145A were antigenically altered and showed impaired recognition by polyclonal HBIG in vitro.


  Hepatitis B virus mutants associated with 3TC and famciclovir administration are replication defective.
 PMID: 9462667       1998       Hepatology (Baltimore, Md.)
1Abstract: In addition, other mutations in the reverse-transcriptase ""B domain"" involving either a phenylalanine (F)-to-leucine (L) at amino acid 501 (F501L) or an L-to-M substitution at amino acid 515 (L515M) have been observed during 3TC and Famciclovir therapy as well."
Abstract: Double mutants with the L515M substitution showed intermediate defect between the YI/VDD or F501L and the L515M single-mutant strains.
Abstract: In both HCC and HEK 293 cells, the mutant viruses carrying the F501L substitution showed a decreased pregenomic RNA encapsidation level, suggesting that the defect in HBV DNA synthesis occ


  Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) --> T, A(1762) --> T and G(1764) --> A mutations in the core promoter.
 PMID: 9472623       1998       The Journal of general virology
Abstract: Hepatitis B virus (HBV) isolates with A-1762 to T and G-1764 to A mutations in the core promoter have been associated with active hepatitis, severe liver disease following liver transplantation, hepatocellular carcinoma and acute fulminant courses--in the latter case combined with a C-1653 to T mutation.


  Proline-138 is essential for the assembly of hepatitis B virus core protein.
 PMID: 9519838       1998       The Journal of general virology
Abstract: We report a mutation study of the region that we have suggested forms an arm-like structure, which reveals that a single mutation, Pro-138 --> Gly, prevents the full-length HBV core protein self-assembling into particles.


  Transient emergence of hepatitis B variants in a patient with chronic hepatitis B resistant to lamivudine.
 PMID: 9551691       1998       Journal of hepatology
Abstract: RESULTS: Sequencing studies of HBV DNA at week 52 showed the emergence of a lamivudine-resistant variant associated with two point mutations in the hepatitis B virus polymerase gene: one mutation led to amino acid substitution of methionine to valine at residue 552, in the highly conserved tyrosine-methionineaspartate-aspartate motif, part of the active site of the polymerase; the second mutation consisted of a substitution of leucine to methionine at residue 528.


  Identification of more than one mutation in the hepatitis B virus polymerase gene arising during prolonged lamivudine treatment.
 PMID: 9593029       1998       The Journal of infectious diseases
Abstract: Analysis of the HBV DNA polymerase gene from 8 chronic hepatitis B patients with suspected resistance to lamivudine showed that in addition to a mutation in the YM552DD motif, a second mutation located in the B domain of this gene, a Leu528-to-Met528 change, was consistently and exclusively found in 4 patients showing the YV552DD motif.


  Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine Clinical Investigation Group.
 PMID: 9620341       1998       Hepatology (Baltimore, Md.)
Abstract: HBV DNA from the sera of patients in Group I exhibits a substitution of valine for methionine at residue 552, accompanied by a substitution of methionine for leucine at residue 528.
Abstract: Patients in Group II had only an isoleucine-for-methionine substitution at position 552.


  Mutation of nucleotide 1,762 in the core promoter region during hepatitis B e seroconversion and its relation to liver damage in hepatitis B e antigen carriers.
 PMID: 9624604       1998       Journal of medical virology
Abstract: The results show that the nucleotide (nt) 1,762 A-->T mutation often develops during HBe seroconversion, particularly in strains without precore mutations that prevent HBeAg production.


  Point mutations in the S and pre-S2 genes observed in two hepatitis B virus carriers positive for antibody to hepatitis B surface antigen.
 PMID: 9638436       1998       Hepato-gastroenterology
Abstract: Seven out of nine S gene clones from case 1 and six out of nine S gene clones from case 2 had an amino acid replacement from Thr or Ile to Ser at codon 126 in the alpha-determinant of the S gene.



Browser Board

 Co-occurred Entities




   Filtrator